FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNSFDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS

Letters | Coronavirus vaccine race: follow the science, not the politics

  • Regulators in the US, China and Russia are all rushing to approve vaccine candidates for use without adequate trials, raising questions about safety

Topic |   World Health Organization
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNSFDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.